This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sieber, F. E. Articles by Faraci, F. M. Search for Related Content PubMed PubMed Citation Articles by Sieber, F. E. Articles by Faraci, F. M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

(Stroke. 1998;29:1445-1453.)
© 1998 American Heart Association, Inc.

Original Contributions

Protein Kinase C Expression and Activity After Global Incomplete Cerebral Ischemia in Dogs

Frederick E. Sieber, MD; Richard J. Traystman, PhD; Phillip R. Brown, DVM; Lee J. Martin, PhD

From the Departments of Anesthesiology and Critical Care Medicine (F.E.S., R.J.T.) and the Department of Comparative Medicine (P.R.B.), the Johns Hopkins Medical Institutions, and the Department of Pathology and Neuroscience, Johns Hopkins University School of Medicine (L.J.M.), Baltimore, Md. Reprint requests to Frederick E. Sieber, MD, Departments of Anesthesiology and Critical Care Medicine, Johns Hopkins University School of Medicine, 600 N Wolfe St, Meyer 8–134, Baltimore, MD 21287-7834.

Background and Purpose—Studies suggest that protein kinase C (PKC) activation during ischemia plays an important role in glutamate neurotoxicity and that PKC inhibition may be neuroprotective. We tested the hypothesis that elevations in the biochemical activity and protein expression of Ca²⁺-dependent PKC isoforms occur in hippocampus and cerebellum during the period of delayed neurodegeneration after mild brain ischemia.

Methods—We used a dog model of 20 minutes of global incomplete ischemia followed by either 6 hours, 1 day, or 7 days of recovery. Changes in PKC expression (Western blotting and immunocytochemistry) and biochemical activity were compared with neuropathology (percent ischemically damaged neurons) by means of hematoxylin and eosin staining.

Results—The percentage of ischemically damaged neurons increased from 13±4% to 52±10% in CA1 and 24±11% to 69±6% in cerebellar Purkinje cells from 1 to 7 days, respectively. The occurrence of neuronal injury was accompanied by sustained increases in PKC activity (240% and 211% of control in hippocampus and cerebellum, respectively) and increased protein phosphorylation as detected by proteins containing phosphoserine residues. By Western blotting, the membrane-enriched fraction showed postischemic changes in protein expression with increases of 146±64% of control in hippocampal PKC and increases of 138±38% of control in cerebellar PKC, but no changes in PKCß and PKC were observed. By immunocytochemistry, the neuropil of CA1 and CA4 in hippocampus and the radial glia in the molecular layer of cerebellum showed increased PKC expression after ischemia.

Conclusions—This study shows that during the period of progressive ischemic neurodegeneration there are regionally specific increases in PKC activity, isoform-specific increases in membrane-associated PKC, and elevated protein phosphorylation at serine sites.

Editorial Comment

Frank M. Faraci, , PhD, Guest Editor

Department of Internal Medicine, Cardiovascular Division, University of Iowa College of Medicine, Iowa City, Iowa

This article has been cited by other articles:

				S. Moriguchi, N. Shioda, H. Maejima, X. Zhao, W. Marszalec, J. Z. Yeh, K. Fukunaga, and T. Narahashi Nefiracetam Potentiates N-Methyl-D-aspartate (NMDA) Receptor Function via Protein Kinase C Activation and Reduces Magnesium Block of NMDA Receptor Mol. Pharmacol., February 1, 2007; 71(2): 580 - 587. [Abstract] [Full Text] [PDF]

				R. Bright and D. Mochly-Rosen The Role of Protein Kinase C in Cerebral Ischemic and Reperfusion Injury Stroke, December 1, 2005; 36(12): 2781 - 2790. [Abstract] [Full Text] [PDF]

				J. Martinez, O. Vogler, J. Casas, F. Barcelo, R. Alemany, J. Prades, T. Nagy, C. Baamonde, P. G. Kasprzyk, S. Teres, et al. Membrane Structure Modulation, Protein Kinase C{alpha} Activation, and Anticancer Activity of Minerval Mol. Pharmacol., February 1, 2005; 67(2): 531 - 540. [Abstract] [Full Text] [PDF]

				R. Bright, A. P. Raval, J. M. Dembner, M. A. Perez-Pinzon, G. K. Steinberg, M. A. Yenari, and D. Mochly-Rosen Protein Kinase C {delta} Mediates Cerebral Reperfusion Injury In Vivo J. Neurosci., August 4, 2004; 24(31): 6880 - 6888. [Abstract] [Full Text] [PDF]

				A. P. Raval, K. R. Dave, D. Mochly-Rosen, T. J. Sick, and M. A. Perez-Pinzon epsilon PKC Is Required for the Induction of Tolerance by Ischemic and NMDA-Mediated Preconditioning in the Organotypic Hippocampal Slice J. Neurosci., January 15, 2003; 23(2): 384 - 391. [Abstract] [Full Text] [PDF]

				S.-F. Yan, J. Lu, Y. S. Zou, J. Soh-Won, D. M. Cohen, P. M. Buttrick, D. R. Cooper, S. F. Steinberg, N. Mackman, D. J. Pinsky, et al. Hypoxia-associated Induction of Early Growth Response-1 Gene Expression J. Biol. Chem., May 21, 1999; 274(21): 15030 - 15040. [Abstract] [Full Text] [PDF]

				C. Iadecola, C. A. Salkowski, F. Zhang, T. Aber, M. Nagayama, S. N. Vogel, and M. Elizabeth Ross The Transcription Factor Interferon Regulatory Factor 1 Is Expressed after Cerebral Ischemia and Contributes to Ischemic Brain Injury J. Exp. Med., February 15, 1999; 189(4): 719 - 727. [Abstract] [Full Text] [PDF]